Dr Shyam K Jaiswal - Top Neurologist in Hitec City, Hyderabad

Brief Profile

Dr. Shyam K. Jaiswal is a Top Neurologist in Hitec City, Hyderabad, with over 12 years of experience in diagnosing and treating a wide range of neurological disorders. As a Senior Consultant Neurologist at CARE Hospitals, HITEC City, he specializes in comprehensive stroke management, epilepsy, Parkinson's disease and other movement disorders, migraine, multiple sclerosis, neuro-immunological conditions, and neuro-critical care. He is highly skilled in advanced treatments, including DBS programming, Botox therapy, and presurgical epilepsy evaluation.

Dr. Jaiswal has led and contributed to several national and international clinical trials in stroke, epilepsy, Parkinson's disease, and migraine. With numerous publications in reputed peer-reviewed journals and active memberships in leading neurological organizations worldwide, he is committed to delivering evidence-based, patient-centered neurological care using the latest advancements in neuroscience.

Field(s) of Expertise

• Comprehensive stroke management
• Epilepsy management with presurgical evaluation & EMU 
• Movement disorders with DBS programming 
• Migraine management with different ladders like MAB, Botox & REN
• Botox therapy for dystonia, post-stroke spasticity, etc 
• Neuro-immunology, including MS, autoimmune disorders, etc 
• Neuro-critical care with brain infections & encephalopathies management

Research and Presentations

• Principal Investigator (PI) – BEAT-ICH Trial in Stroke (February 2026 – Present); Title: Reducing the Burden of Cardiovascular Events with Antiplatelet Therapy in Patients with Intracerebral Hemorrhage (ICH).
• Principal Investigator (PI) – STENOSIS Trial in Stroke (August 2022 – Present); Title: Use of Dual Antiplatelet Therapy to Prevent Recurrence of Ischemic Stroke.
• Principal Investigator (PI) – MOBILITY Trial in Stroke (September 2023 – Present); Title: Use of a Mobile-Based Application to Improve Outcomes in Patients with Stroke.
• Co-Investigator – INSTRuCT Phase II Trial in Stroke (August 2022 – Present); Title: Evaluation of Drug Therapy in Patients with Intracerebral Hemorrhage (IC Bleed).
• Co-Investigator – INSTRuCT Phase I Trial in Stroke (2018 – 2022); Contribution: Played a pivotal role as a member of the Indian Stroke Clinical Trial (INSTRuCT) Network, contributing to research in advanced acute stroke management, stroke prevention, recovery, and rehabilitation following stroke.
• Co-Investigator – Late Referral for Epilepsy Surgery Study (2022 – 2023)
• Principal Investigator (PI) – PRIDE Study in Epilepsy (June 2024 – Present)
• Principal Investigator (PI) – GUT–Brain–PD Study in Parkinson's Disease (PD) (June 2024 – Present)
• Principal Investigator (PI) – Nerivio® REN Device Study in Migraine (June 2024 – Present)

Publications

• S Jaiswal. Determining seizure types and epilepsy based on ILAE (2014) classification in a south Indian tertiary care hospital. Epilepsia.2025:66(2):20 doi:10.1111/epi.18527.
• S.Jaiswal. Different Etiologies of Acute Ischemic Stroke by TOAST Classification: A Tertiary care Hospital-Inpatient Data from South India. Int J Stroke. 2024;19(2_suppl):3-498. doi:10.1177/17474930241274956
• Jaiswal SK, Murthy JMK, Pidaparthi L, Yerasu MR, Yeduguri SR. Refractory Status Epilepticus in a Patient with SARS-CoV2 Infection: Possible Mechanisms. Ann Indian Acad Neurol. 2022 Mar-Apr;25(2):271-273.
• Pandian JD, Kante MP, Jaiswal S K, et al.Secondary prevention with a structured semi-interactive stroke prevention package in INDIA (SPRINT INDIA): a multicentre, randomised controlled trial. Lancet Glob Health. 2023;11(3):e425-e435. doi:10.1016/S2214-109X(22)00544-7
• Pandian JD, Phillips A, Jaiswal S K, et al. Indian Trial of    Tranexamic acid in Spontaneous Intracerebral Hemorrhage study protocol. Int J Stroke. 2025;20(6):756-762. doi:10.1177/17474930241307933
• Neeraj Bahetia, Chaturbhuj Rathore , Atma Ram Bansal  , Saumya Shah  , Hari Kunhi Veedu , Sanjay Prakash , Kalyani Kanhere  , Shyam K. Jaiswal , Anis Jukkarwala , Jagarlapudi , K. Murthy , Kurupath Radhakrishnan. Treatment outcomes in drug resistant juvenile myoclonic epilepsy: Valproate resistance may not be the end of the road,Seizure:European Journal of Epilepsy.2021 Aug;92 : 112-117.
• Murthy JM, Jaiswal SK, Gaade KA. Posterior Reversible Encephalopathy Syndrome Is the Common Cause of New-Onset Seizures in the Peripartum Period: A Tertiary Hospital-Based Study in South India. J Epilepsy Res. 2021 Jun 30;11(1):49-55.
• Rathore C, Baheti N, Bansal AR, Jabeen SA, Gopinath S, Jagtap S, Patil S, Suryaprabha T, Jayalakshmi S, Ravat S, Nayak DS, Prakash S, Rana K, Jaiswal SK, Khan FR, Murthy JM, Radhakrishnan K. Impact of COVID-19 pandemic on epilepsy practice in India: A tripartite survey. Seizure. 2021 Mar;86:60-67.
• Fearon C, Rawal S, Olszewska D, Alcaide-Leon P, Kern DS, Sharma S, Jaiswal SK, Murthy JMK, Ha AD, Schwartz RS, Fung VSC, Spears C, Tholanikunnel T, Almeida L, Hatano T, Oji Y, Hattori N, Shubham S, Kumar H, Bhidayasiri R, Laohathai C, Lang AE. Neuroimaging Pearls from the MDS Congress Video Challenge. Part 2: Acquired Disorders. Mov Disord Clin Pract. 2022 Feb 3;9(3):311-325. 
• Murthy JMK, Jaiswal SK, Reddy MP, Sri Krishna S. Incidence Study of Epilepsy using the ILAE 2017 Classification of Epilepsies in a Cohort of School Children Accessing Education in Government Primary Schools in South India. Neurol India. 2020 Nov-Dec;68(6):1389-1393.
• Jaiswal SK, Murthy JMK, Reddy MP, Sri Krishna S. Incidence of seizures due to degenerative phase of neurocysticercosis: A study in a cohort of primary school children in south India. Neurology Asia 2019; 24(2) : 121 – 125
• Study of subtypes of first ever acute ischemic stroke by TOAST classification: A tertiary care hospital-based study from south India , International Journal of Stroke , 2016 (538, P. 211, Vol 11, Issue 3 suppl).
• Clinical profile of Migraine (based on ICHD-3 Beta classification) : an urban private hospital based observational study in south India , Cephalgia ( under press).
• Jaiswal SK. Headache as a Neurological Manifestation in SLE: Is It a Red Flag? Cephalalgia.2012;33(11):63.

Education

• MBBS- SETH G.S. Medical College & K.E.M. Hospital, Mumbai (1998 - 2003)
• MD (Internal Medicine) from V.M. Medical College & Govt. Hospital, Solapur, Maharashtra (May 2005 - April 2008)
• DNB, Neurology from Care Institute of Medical Science, Hyderabad

Awards and Recognitions

• Received Young Scholarship Award-Travel Bursary for presentation at 12th World Congress on Controversies in Neurology (CONy) at Warsaw, Poland in March 2018.
• Awarded Second Prize for Clinical Case Solution presented at 5th Annual Conference of Clinical Neurology Shine at Chennai, India in the year March 2015

Languages Known

English, Hindi, Telugu, Kannada, Marathi, Bengali

Fellowship/Membership

• A member of International League Against Epilepsy (ILAE) 
• A Life Member of the Indian Epilepsy Association (IEA) 
• A Life Member of the Indian Epilepsy Society (IES)
• A Member of the World Stroke Organization (WSO) 
• A Member of the Indian Stroke Association (ISA) 
• A Member of the International Parkinson & Movement  Disorder Society (MDS)
• A Member of the Movement  Disorder Society of India (MDSI)
• A  Member of the International Headache Society (IHS)
• A  Member of the American Academy of Neurology (AAN)
• A Life Member of the Indian Academy of Neurology (IAN)
• A Life Member of the Andhra Pradesh Neuroscientists Association (APNSA)